Literature DB >> 22877734

PolyMorphine: an innovative biodegradable polymer drug for extended pain relief.

Roselin Rosario-Meléndez1, Carolyn L Harris, Roberto Delgado-Rivera, Lei Yu, Kathryn E Uhrich.   

Abstract

Morphine, a potent narcotic analgesic used for the treatment of acute and chronic pain, was chemically incorporated into a poly(anhydride-ester) backbone. The polymer termed "PolyMorphine", was designed to degrade hydrolytically releasing morphine in a controlled manner to ultimately provide analgesia for an extended time period. PolyMorphine was synthesized via melt-condensation polymerization and its structure was characterized using proton and carbon nuclear magnetic resonance spectroscopies, and infrared spectroscopy. The weight-average molecular weight and the thermal properties were determined. The hydrolytic degradation pathway of the polymer was determined by in vitro studies, showing that free morphine is released. In vitro cytocompatibility studies demonstrated that PolyMorphine is non-cytotoxic towards fibroblasts. In vivo studies using mice showed that PolyMorphine provides analgesia for 3 days, 20 times the analgesic window of free morphine. The animals retained full responsiveness to morphine after being subjected to an acute morphine challenge.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22877734      PMCID: PMC3455147          DOI: 10.1016/j.jconrel.2012.07.033

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  41 in total

Review 1.  Cellular and synaptic adaptations mediating opioid dependence.

Authors:  J T Williams; M J Christie; O Manzoni
Journal:  Physiol Rev       Date:  2001-01       Impact factor: 37.312

2.  Comparative study of morphine diffusion from sustained release polymeric suspensions.

Authors:  M E Morales; V Gallardo Lara; A C Calpena; J Doménech; M A Ruiz
Journal:  J Control Release       Date:  2004-02-20       Impact factor: 9.776

Review 3.  Opiate tolerance and dependence: receptors, G-proteins, and antiopiates.

Authors:  L M Harrison; A J Kastin; J E Zadina
Journal:  Peptides       Date:  1998       Impact factor: 3.750

Review 4.  Mechanisms of polymer degradation and erosion.

Authors:  A Göpferich
Journal:  Biomaterials       Date:  1996-01       Impact factor: 12.479

5.  Efficacy, safety, and steady-state pharmacokinetics of once-a-day controlled-release morphine (MS Contin XL) in cancer pain.

Authors:  Neil A Hagen; Michael Thirlwell; John Eisenhoffer; Patricia Quigley; Zoltan Harsanyi; Andrew Darke
Journal:  J Pain Symptom Manage       Date:  2005-01       Impact factor: 3.612

6.  Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain.

Authors:  Russell K Portenoy; Andréa Sciberras; Lise Eliot; Gordon Loewen; Jackie Butler; John Devane
Journal:  J Pain Symptom Manage       Date:  2002-04       Impact factor: 3.612

7.  Comparison of salicylate-based poly(anhydride-esters) formed via melt-condensation versus solution polymerization.

Authors:  Robert C Schmeltzer; Michelle Johnson; Jeremy Griffin; Kathryn Uhrich
Journal:  J Biomater Sci Polym Ed       Date:  2008       Impact factor: 3.517

Review 8.  Clinical pharmacokinetics of morphine.

Authors:  Ralph A Lugo; Steven E Kern
Journal:  J Pain Palliat Care Pharmacother       Date:  2002

9.  Extended-release formulation of morphine for subcutaneous administration.

Authors:  T Kim; J Kim; S Kim
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

10.  Effect of Linker Structure on Salicylic Acid-Derived Poly(anhydride-esters).

Authors:  Almudena Prudencio; Robert C Schmeltzer; Kathryn E Uhrich
Journal:  Macromolecules       Date:  2005       Impact factor: 5.985

View more
  8 in total

Review 1.  One-component nanomedicine.

Authors:  Hao Su; Jin Mo Koo; Honggang Cui
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

2.  Ring-opening polymerization of prodrugs: a versatile approach to prepare well-defined drug-loaded nanoparticles.

Authors:  Jinyao Liu; Wenge Liu; Isaac Weitzhandler; Jayanta Bhattacharyya; Xinghai Li; Jing Wang; Yizhi Qi; Somnath Bhattacharjee; Ashutosh Chilkoti
Journal:  Angew Chem Int Ed Engl       Date:  2014-11-26       Impact factor: 15.336

3.  Polyactives: controlled and sustained bioactive release via hydrolytic degradation.

Authors:  N D Stebbins; J J Faig; W Yu; R Guliyev; K E Uhrich
Journal:  Biomater Sci       Date:  2015-06-02       Impact factor: 6.843

4.  Covalent Poly(lactic acid) Nanoparticles for the Sustained Delivery of Naloxone.

Authors:  Andrew J Kassick; Heather N Allen; Saigopalakrishna S Yerneni; Fathima Pary; Marina Kovaliov; Cooper Cheng; Marco Pravetoni; Nestor D Tomycz; Donald M Whiting; Toby L Nelson; Michael Feasel; Phil G Campbell; Benedict Kolber; Saadyah Averick
Journal:  ACS Appl Bio Mater       Date:  2019-07-25

Review 5.  Anticancer nanoparticulate polymer-drug conjugate.

Authors:  Quanyou Feng; Rong Tong
Journal:  Bioeng Transl Med       Date:  2016-10-28

6.  Biomedical Applications of Nanotechnology and Nanomaterials.

Authors:  Vinay Bhardwaj; Ajeet Kaushik
Journal:  Micromachines (Basel)       Date:  2017-10-02       Impact factor: 2.891

7.  Poly(anhydride-esters) comprised exclusively of naturally occurring antimicrobials and EDTA: antioxidant and antibacterial activities.

Authors:  Ashley L Carbone-Howell; Nicholas D Stebbins; Kathryn E Uhrich
Journal:  Biomacromolecules       Date:  2014-04-17       Impact factor: 6.988

8.  PolyMorphine provides extended analgesic-like effects in mice with spared nerve injury.

Authors:  Neil C Lax; Renxun Chen; Sarah R Leep; Kathryn Uhrich; Lei Yu; Benedict Kolber
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.